GlassScriptPhysician profile
Jon J Bellantoni
NPI 1639161169
$2,709.67
in general payments reported to CMS, 2019-2025
34 companies · $13.75 in 2025
The $13.75 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $457 · 2021: $301 · 2022: $596 · 2023: $212 · 2024: $439 · 2025: $13.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631 · Education: $32.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.38 |
| Education | $32.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $463.37 | 2019-2022 | |
| Coopersurgical, INC. | $300.94 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $270.85 | 2022-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $177.69 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.13 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $146.55 | 2019-2021 | |
| Pfizer INC. | $120.78 | 2021-2024 | |
| Hologic Sales and Service, LLC | $114.59 | 2019-2024 | Aptima, Omni Hysteroscope, Novasure |
| Organon LLC | $93.60 | 2021-2024 | Nexplanon |
| Renovia INC | $79.46 | 2019 | |
| Daiichi Sankyo INC. | $76.66 | 2022 | |
| Millicent US INC | $75.22 | 2020-2024 | Femring, Intrarosa |
| Exeltis, USA INC. | $55.86 | 2022-2023 | Slynd |
| Ethicon US, LLC | $53.08 | 2021-2025 | Stratafix, Harmonic, Ethicon |
| Amgen INC. | $48.48 | 2020-2023 | Evenity, Prolia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $47.43 | 2019 | |
| Allergan, INC. | $47.41 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $42.21 | 2022-2024 | |
| Sage Therapeutics, LLC | $31.85 | 2024 | |
| Minerva Surgical, INC | $30.86 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $30.80 | 2019 | |
| Covidien LP | $25.99 | 2019 | |
| Agile Therapeutics, INC. | $22.42 | 2021 | |
| Optumhealth Care Solutions, LLC | $21.54 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Roche Diagnostics Corporation | $20.73 | 2019 | |
| Myovant Sciences INC. | $20.25 | 2022 | |
| Evofem Biosciences, INC. | $18.12 | 2021 | |
| Aspira Women'S Health INC | $17.26 | 2024 | Ova1 |
| Abbott Laboratories | $17.05 | 2021 | |
| Sumitomo Pharma America, INC. | $16.00 | 2023 | Myfembree |
| Medtronic Vascular, INC. | $15.55 | 2020 | |
| Avion Pharmaceuticals | $15.46 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.94 | 2020 | |
| Meditrina | $14.54 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Bellantoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.